Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tefibazumab, a humanized IgG1κ monoclonal antibody, targets and binds to clumping factor A, an adhesion protein expressed on the surface of Staphylococcus aureus, and is under investigation for the treatment of serious Staphylococcus aureus infections [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Tefibazumab, a humanized IgG1κ monoclonal antibody, targets and binds to clumping factor A, an adhesion protein expressed on the surface of Staphylococcus aureus, and is under investigation for the treatment of serious Staphylococcus aureus infections [1] [2]. |
In vitro | Tefibazumab features an antigen-binding region composed of variable amino acid sequences from human (>98%) and murine (<2%) origins. |
Synonyms | INH-H 2002 |
Molecular Weight | N/A |
CAS No. | 521079-87-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tefibazumab 521079-87-8 INH-H 2002 inhibitor inhibit